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Abstract Bio-Rad MRSASelect™ medium was evaluated
for its ability to recover methicillin-resistant Staphylococcus
aureus (MRSA) from nasal samples of pig farmers and their
household members. In total, 257 samples were inoculated
on Bio-Rad MRSASelect™ medium with and without broth
enrichment and on bioMérieux MRSA ID with broth
enrichment. A sample was considered to be positive if at
least one of the media grew MRSA. The sensitivity of Bio-
Rad MRSASelect™ medium without broth enrichment was
63.9%. With broth enrichment, the sensitivity increased to
98.4%. The specificity was 95.4% both with and without
broth enrichment. In conclusion, Bio-Rad MRSASelect™
medium as well as MRSA ID medium are reliable methods
to detect MRSA carriage when used in combination with
broth enrichment. The directly inoculated MRSASelect™
medium was statistically significantly less sensitive than the
two media after broth enrichment.
First described in 1961, methicillin-resistant Staphylococcus
aureus (MRSA) has emerged worldwide as a nosocomial
pathogen of major importance, and the incidence of
infections caused by MRSA continues to increase [1, 2].
Since the 1990s, MRSA has also emerged in the community
[3]. In addition, a new clone has been identified, which is
related to an extensive reservoir in animals. Persons who are
in direct contact with pigs frequently carry this livestock-
associated MRSA (LA-MRSA) [4, 5].
Laboratory-based screening for MRSA colonization
of patients and health care workers remains a
cornerstone of infection control measures to limit the
spread of this organism [6]. Methods to detect MRSA in
clinical samples should ideally have a high sensitivity and
specificity, combined with a short time to reporting of the
results. To identify S. aureus from contaminated samples
more easily and reliably, selective media have been
developed [7]. The extension of MRSA beyond its
previously known boundaries to livestock-related persons
poses a challenge for microbiological laboratories to
improve their screening strategies. The purpose of this
study is to evaluate the in vivo sensitivity and specificity
of a new selective medium for the detection of MRSA
from nasal samples taken from people living or working
on pig farms.
MRSASelect™ is a chromogenic medium for the identi-
fication of MRSA in human specimens and was supplied as
prepoured culture plates from Bio-Rad, Hercules, California,
USA. The composition of the chromogenic and selective
mix is proprietary. On MRSASelect™, MRSA strains form
distinctive pink colonies. The selective mixture inhibits
methicillin-susceptible S. aureus (MSSA) strains, most
bacteria not belonging to the genus Staphylococcus, and
yeasts. Results can be read after 18–28 h, according to the
manufacturer.
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Nasal samples were taken from pig farmers, their co-
workers, and their household members as part of an ongoing
study and sent bymail to the Laboratory for Microbiology and
Infection Control at the Amphia Hospital, the Netherlands.
Samples were inoculated onto MRSASelect™ medium and
diluted with a sterile loop using a three-streak dilution
method. In addition, a broth enrichment containing Mueller–
Hinton broth with 6.5% NaCl was inoculated using the same
swab, and this was incubated overnight at 35°C. Subse-
quently, 10 μl of the broth enrichment was inoculated onto
both MRSASelect™ and MRSA ID (bioMérieux, La Balme
Les Grottes, France). Both sets of plates were read after 18–
28 h of incubation at 35–37°C. Growth of colonies on the
MRSASelect™ agar plates showing pink coloration or
growth of colonies with green coloration on the MRSA ID
agar plates were considered to be indicative for MRSA. No
growth or colonies with colors other than pink or green were
considered to be negative. Presumptive S. aureus colonies
were further identified by a latex agglutination test (Slidex™
Staph-Kit; bioMérieux, La Balme Les Grottes, France), and
by the detection of DNase (Oxoid DNase agar; Thermo
Fisher Scientific, Basingstoke, UK). When isolates were
identified as S. aureus, the methicillin susceptibility was
tested using the cefoxitin disk diffusion test according to the
Clinical and Laboratory Standards Institute (CLSI; formerly
the National Committee on Clinical Laboratory Standards
[NCCLS]) standards [8]. All cefoxitin-resistant isolates were
confirmed to be MRSA using a duplex polymerase chain
reaction (PCR) assay for the mecA gene and the coagulase
gene as described previously [9, 10], and this was considered
to be the “gold standard.” When MRSAwas recovered from
one or more of the media, the sample was considered to be
positive.
A total of 257 freshly collected nasal samples originating
from different individuals were analyzed in this study.
When combined results for all media were analyzed, 61 of
the 257 (23.7%) samples were identified as positive for
MRSA. The results obtained with MRSASelect™ medium
and MRSA ID medium are shown in Table 1. When used in
combination with broth enrichment, the sensitivity of
MRSASelect™ was comparable to MRSA ID. The directly
inoculated MRSASelect™ was statistically significantly
less sensitive than the two media after broth enrichment.
After broth enrichment, MRSASelect™ grew nine and
MRSA ID grew ten false-positive strains. These false-
positive strains were not further identified. This results in
specificities of 95.4 and 94.9%, respectively (p=1.0). The
specificity of the directly inoculated MRSASelect™ medi-
um was also 95.4%. In combination with broth enrichment,
the positive predictive values (PPV) of MRSASelect™ and
of MRSA ID were 87.0 and 85.9%, respectively (p=1.0).
The negative predictive values (NPV) were 99.5 and
100.0%, respectively (p=1.0). The PPV and NPV of
directly inoculated MRSASelect™ were 81.3 and 89.5%,
respectively.
We evaluated the in vivo performance of MRSASelect™
medium and MRSA ID medium with and without broth
enrichment in a population with a high prevalence of
MRSA carriage. Both media had high sensitivities and
adequate specificities when used in combination with broth
enrichment. However, without broth enrichment, the sensi-
tivities were significantly lower. This confirms the impor-
tance of broth enrichment for the accurate detection of
MRSA in clinical samples [11].
The sensitivity and specificity found in this clinical
evaluation are significantly lower than recent findings in
other studies [12, 13]. Stoakes et al. [12] compared
MRSASelect™ medium with CHROMagar, mannitol-salt
agar with oxacillin, and mannitol-salt agar with cefoxitin.
In this study, nasal and perineal swabs were routinely
collected from all patients admitted to the hospital who
had been admitted to any health care facility in the
previous 6 months. They processed a total of 2,125
(1,243 nasal and 882 perineal) consecutive swabs and
found that three from the 111 confirmed MRSA strains
were not detected by MRSASelect™ medium (sensitivity
of 97.3%). Ben Nsira et al. [13] screened 666 samples
using MRSASelect™ medium and three other selective
media. Ninety-nine samples were positive for MRSA on at
least one selective medium. Only one MRSA isolate was
missed on MRSASelect™ medium (sensitivity of 99.8%).
The discrepancy between the sensitivities obtained in
these two studies in comparison to the direct plating in
our study is most likely caused by the addition of broth
enrichment in our culture procedure. This improves the
sensitivity of the reference method substantially and,
Table 1 Analytical performance of MRSASelect™ and MRSA ID medium in a prospective clinical study of nasal swabs (n=257, including n=61
MRSA-positive samples)
Medium Method True-positive False-positive Sensitivity % Specificity % PPV % NPV %
MRSASelect™ Direct 39 9 63.9 95.4 81.3 89.5
Enrichment 60 9 98.4 95.4 87.0 99.5
MRSA ID Enrichment 61 10 100 94.9 85.9 100
PPV, positive predictive value; NPV, negative predictive value
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thereby, reduces the sensitivity of the test that is evaluated
(in this case, the direct plating method). Another explanation
for the discrepancy between the specificity found in our
evaluation and in some other studies may be that we screened
a specific population, i.e., pig farmers and their household
members, who carry a specific clone of MRSA, namely,
LA-MRSA, and these strains all belong to multilocus
sequence type 398 (ST398) [4, 5, 16, 17]. Therefore, our
results do not necessarily apply to other types of MRSA.
A study that reported similar results to our findings was
performed by van Loo et al. [11]. In total, they tested 3,000
samples from 409 patients for the presence of MRSA. Every
sample was directly inoculated onto an MRSASelect™
medium. Fifty-five out of 70 true-positive samples (sensitiv-
ity 78.6%) were detected by the MRSASelect™ medium
after 48 h of incubation. Subsequently, the investigators
subcultured 225 samples from a broth enrichment containing
Mueller–Hinton broth with 6 μg/ml oxacillin and 6 μg/ml
aztreonam on the MRSASelect™ medium. This increased
the yield of MRSA containing samples by 12%. Our
increase was much larger, which may be explained by the
choice of the type of broth enrichment. However, the present
study used a less selective broth enrichment than van Loo et
al. A recent study found that the broth enrichment as used by
van Loo et al. resulted in suboptimal performance [14].
In another recent study, Nonhoff et al. [15] evaluated the
performance of three chromogenic media, MRSA ID,
MRSA Screen, and MRSASelect™, in combination with
broth enrichment for the detection of MRSA in 1,002
mucocutaneous swabs from 639 hospitalized patients. A
sample was considered to be positive when MRSA was
isolated from any of the three media tested. MRSA strains
were isolated from 68 (6.8%) specimens from 44 patients.
The sensitivity of all chromogenic media was <50% after
18 h of incubation, but increased with prolonged incubation
at 42 h to 75, 80.9, and 72.1% for MRSA ID, MRSA
Screen, and MRSASelect™, respectively. The difference in
sensitivity between MRSA Screen and MRSASelect™ after
42 h was significant. After enrichment, the sensitivity for
all media was 85.3% at 24 h of incubation. The specificity
was excellent for MRSA ID (99.9%) and MRSASelect™
(100%) after 18 h, and lower for MRSA Screen (97.2%),
albeit not statistically significantly so. This study confirms
the additional yield of broth enrichment and is comparable
to our findings. Comparison of the results of all the above-
mentioned studies with our current evaluation is not easy
because of differences in the study design: swab type, body
site sampled, direct inoculation versus prior homogeniza-
tion in saline or broth, incubation time, use or not of broth
enrichment, and, most importantly, the nature of the test
chosen as the gold standard.
The results of our study have one important limitation.
We sampled a specific population, i.e., pig farmers, who
carry a specific clone of MRSA, namely, LA-MRSA.
Therefore, the performance may be different for other types
of MRSA. There are several studies which reported that
persons working with pigs frequently carry LA-MRSA [4,
16, 17]. van Loo et al. [4] performed a case–control study
and showed that carriers of LA-MRSAwere more often pig
or cattle farmers. Thirty-four of 35 case-patients carried
ST398; one had ST9. In addition, Wulf et al. [16] reported
that veterinarians at an international conference on pig
health frequently carried MRSA. Thirty-one of the 34
isolates were non-typeable by pulsed-field gel electropho-
resis (PFGE) following SmaI digestion of chromosomal
DNA. All of the non-typeable isolates belonged to spa
types that correspond to ST398 (t011, t034, t108, t571,
t567, and t899). Finally, van den Broek et al. [17]
demonstrated that intensive and repeated exposure to pigs
is an important factor in MRSA colonization and that this is
almost always ST398. Although we did not perform
molecular typing, it is beyond reasonable doubt that the
vast majority of the MRSA strains recovered in our study
belonged to ST398 . The conclusion is that MRSASelect™
medium and MRSA ID medium in combination with broth
enrichment are useful tools for the detection of LA-MRSA
in nasal samples. In this study, the MRSASelect™ medium
and MRSA ID medium were equivalent and can be used
indifferently. The additional yield of the broth enrichment
was comparable to what has been reported previously and
is considered to be the standard for screening of MRSA.
After direct inoculation or subculture of broth enrichment,
typical MRSA colonies need to be confirmed by further
testing.
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